Rethinking malaria vaccines: perspectives on currently approved malaria vaccines in India's path to elimination

被引：0

作者：

Ranjha, Ritesh ^{[1
,2
]}

Bai, Priyanka ^{[1
,2
]}

Singh, Kuldeep ^{[1
,2
]}

Mohan, Mradul ^{[1
,2
]}

Bharti, Praveen K. ^{[1
,2
]}

Anvikar, Anup R. ^{[1
]}

机构：

[1] ICMR Natl Inst Malaria Res, New Delhi, India

[2] Acad Sci & Innovat Res AcSIR, Ghaziabad, Uttar Pradesh, India

来源：

BMJ GLOBAL HEALTH | 2024年 / 9卷 / 08期

关键词：

Malaria; Vaccines; India; CHILDREN;

D O I：

10.1136/bmjgh-2024-016019

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

double right arrow Existing malaria intervention strategies require an additional tool to control and eliminate malaria. double right arrow The promising safety and efficacy of the R21 vaccine make it an effective intervention strategy for malaria elimination. double right arrow Prevalence of both P. falciparum and P. vivax in children under five, in different malaria transmission settings in India needs to be considered. double right arrow A vaccine that targets both P. falciparum and P. vivax in all age groups and inhibits transmission will be more suitable for India's malaria elimination goal. double right arrow An effective and sustainable vaccine as a complementary intervention strategy may require operational research evidencE

引用

页数：4

共 21 条

[1] Complicated vivax malaria, an often underestimated condition - Case Report [J].

Aashish, Arumugam ;

Manigandan, Gopi .

JOURNAL OF FAMILY AND COMMUNITY MEDICINE, 2015, 22 (03) :180-182

[2]

[Anonymous], 2023, World malaria report 2023

[3]

[Anonymous], 2023, 18 million doses of first-ever malaria vaccine allocated to 12 African countries for 2023-2025 [Internet]

[4] A micro-epidemiological report on the unstable transmission of malaria in Aligarh, India [J].

Aqeel, Sana ;

Naheda, Ansari ;

Raza, Adil ;

Khan, Wajihullah .

PARASITE EPIDEMIOLOGY AND CONTROL, 2020, 11

[5] Four decades of epidemiological data reveal trajectories towards malaria elimination in Kheda district (Gujarat), western part of India [J].

Baharia, Rajendra Kumar ;

Yadav, Chander Prakash ;

Sharma, Amit .

BMJ GLOBAL HEALTH, 2021, 6 (12)

[6] Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial [J].

Datoo, Mehreen S. ;

Natama, Magloire H. ;

Some, Athanase ;

Traore, Ousmane ;

Rouamba, Toussaint ;

Bellamy, Duncan ;

Yameogo, Prisca ;

Valia, Daniel ;

Tegneri, Moubarak ;

Ouedraogo, Florence ;

Soma, Rachidatou ;

Sawadogo, Seydou ;

Sorgho, Faizatou ;

Derra, Karim ;

Rouamba, Eli ;

Orindi, Benedict ;

Lopez, Fernando Ramos ;

Flaxman, Amy ;

Cappuccini, Federica ;

Kailath, Reshma ;

Elias, Sean ;

Mukhopadhyay, Ekta ;

Noe, Andres ;

Cairns, Matthew ;

Lawrie, Alison ;

Roberts, Rachel ;

Valea, Innocent ;

Sorgho, Hermann ;

Williams, Nicola ;

Glenn, Gregory ;

Fries, Louis ;

Reimer, Jenny ;

Ewer, Katie J. ;

Shaligram, Umesh ;

Hill, Adrian V. S. ;

Tinto, Halidou .

LANCET, 2021, 397 (10287) :1809-1818

[7] Issues related to the approval of the R21/Matrix-M malaria vaccine for use in Nigeria and Ghana [J].

Dzi, Kevin T. J. .

FRONTIERS IN PUBLIC HEALTH, 2023, 11

[8] Burden of Complicated Malaria in a Densely Forested Bastar Region of Chhattisgarh State (Central India) [J].

Jain, Vidhan ;

Basak, Sanjay ;

Bhandari, Sneha ;

Bharti, Praveen K. ;

Thomas, Trilok ;

Singh, Mrigendra P. ;

Singh, Neeru .

PLOS ONE, 2014, 9 (12)

[9]

Kannambath Rachana, 2023, Trop Parasitol, V13, P28, DOI 10.4103/tp.tp_41_22

[10] RTS,S/AS01 vaccine (Mosquirix?): an overview [J].

Laurens, Matthew B. .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (03) :480-489

← 1 2 3 →